Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Biopharmaceutical Factors Influencing Drug Product Design: Overview01:22

Biopharmaceutical Factors Influencing Drug Product Design: Overview

Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though pharmacologically...
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
Modified-Release Drug Delivery Systems: Rate-Programmed II01:19

Modified-Release Drug Delivery Systems: Rate-Programmed II

Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Modified-Release Drug Delivery Systems: Classification01:23

Modified-Release Drug Delivery Systems: Classification

Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Design of a Targeted Covalent Probe to Interrogate the DNA Polymerase Activity of Polθ.

ACS medicinal chemistry letters·2026
Same author

The Discovery of RP-2119: A Potent, Selective, and Orally Bioavailable Polθ ATPase Inhibitor.

Journal of medicinal chemistry·2025
Same author

Discovery of RP-1664: A First-in-Class Orally Bioavailable, Selective PLK4 Inhibitor.

Journal of medicinal chemistry·2025
Same author

Multiscale modeling shows how 2'-deoxy-ATP rescues ventricular function in heart failure.

Proceedings of the National Academy of Sciences of the United States of America·2024
Same author

Dilated cardiomyopathy mutation in beta-cardiac myosin enhances actin activation of the power stroke and phosphate release.

PNAS nexus·2024
Same author

Targeting Tuberculosis: Novel Scaffolds for Inhibiting Cytochrome <i>bd</i> Oxidase.

Journal of chemical information and modeling·2024

関連する実験動画

Updated: Jul 7, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

受容器の柔軟性を考慮した計算による薬物設計: リラックスされた複合体スキーム.

Jung-Hsin Lin1, Alexander L Perryman, Julie R Schames

  • 1Howard Hughes Medical Institute, Department of Chemistry & Biochemistry, and Department of Pharmacology, University of California at San Diego, 92093-0365, USA. jlin@maccammon.ucsd.edu

Journal of the American Chemical Society
|May 16, 2002
PubMed
まとめ

新しい計算による薬剤設計法である"リラックス・コンプレックス"は,受容体の柔軟性を説明する. 最適なリガンド-酵素結合モードを特定し,強力な薬の開発を可能にします.

さらに関連する動画

Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach
10:01

Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach

Published on: June 23, 2026

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

関連する実験動画

Last Updated: Jul 7, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach
10:01

Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach

Published on: June 23, 2026

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

科学分野:

  • 計算化学はコンピュータ化学である.
  • ドラッグ・ディスカバリー・ドラッグ・ディスカバリー
  • 構造生物学 構造生物学とは

背景:

  • 薬剤設計において受容体の柔軟性は極めて重要ですが,従来の方法ではしばしば見過ごされます.
  • リガンド結合は,希少な受容体構成に敏感である可能性があります.
  • NMRによるSARやテザリングによるSARのような既存の実験的方法は,ビルディングブロックのアプローチを提供しています.

研究 の 目的:

  • 薬剤設計のための新しい計算方法論を導入し,受容体の柔軟性を組み込む.
  • ダイナミックな受容体-リガンド相互作用のモデリングにおける既存の計算方法の限界に対処する.
  • 実験的な構造-活動関係技術に計算上の類似性を提供すること.

主な方法:

  • この研究では",リラックス・コンプレックス"計算方法について説明しています.
  • このアプローチは,潜在的に希少な受容体構成へのリガンド結合をモデル化しています.
  • それは,リガンド-酵素結合モードの酵素構成に対する感受性を分析します.

主要な成果:

  • リラックス・コンプレックス・メソッドは,最適なリガンド-酵素複合体を成功裏に特定します.
  • このアプローチは,酵素構成が結合モードに与える重要な影響を実証しています.
  • 強力な薬剤を設計するための計算戦略を提供します.

結論:

  • リラックス・コンプレックス・メソッドは,コンピュータによる薬物設計における重要な進歩である.
  • この方法論は,受容体ダイナミクスを考慮することによって,非常に効果的な薬の発見を可能にします.
  • 構造ベースの薬物開発のための貴重な計算ツールとして機能します.